Nathaniel Wallace

621 total citations
15 papers, 483 citations indexed

About

Nathaniel Wallace is a scholar working on Molecular Biology, Sensory Systems and Pharmacology. According to data from OpenAlex, Nathaniel Wallace has authored 15 papers receiving a total of 483 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 4 papers in Sensory Systems and 3 papers in Pharmacology. Recurrent topics in Nathaniel Wallace's work include Ion Channels and Receptors (4 papers), Pharmacological Receptor Mechanisms and Effects (3 papers) and Gastrointestinal motility and disorders (2 papers). Nathaniel Wallace is often cited by papers focused on Ion Channels and Receptors (4 papers), Pharmacological Receptor Mechanisms and Effects (3 papers) and Gastrointestinal motility and disorders (2 papers). Nathaniel Wallace collaborates with scholars based in United States. Nathaniel Wallace's co-authors include Pamela J. Hornby, Edward S. Kimball, Craig R. Schneider, M. R. D’Andrea, Kevin P. Pavlick, Robert W. Tuman, Michael R. D’Andrea, Charles R. Bowden, David M. Morris and Wei He and has published in prestigious journals such as The Journal of Clinical Endocrinology & Metabolism, Diabetes and Journal of Medicinal Chemistry.

In The Last Decade

Nathaniel Wallace

15 papers receiving 477 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Nathaniel Wallace United States 11 169 119 99 84 79 15 483
Piotr K. Zakrzewski Poland 13 108 0.6× 156 1.3× 70 0.7× 124 1.5× 84 1.1× 21 484
Hiroyuki Ohshiro Japan 8 83 0.5× 107 0.9× 29 0.3× 99 1.2× 25 0.3× 10 374
Rocı́o Girón Spain 15 154 0.9× 203 1.7× 37 0.4× 168 2.0× 21 0.3× 39 520
Michael Respondek Germany 13 282 1.7× 115 1.0× 47 0.5× 118 1.4× 71 0.9× 20 696
Yusaku Komoike Japan 15 301 1.8× 93 0.8× 19 0.2× 70 0.8× 58 0.7× 21 579
Yoko Kogure Japan 12 29 0.2× 105 0.9× 129 1.3× 108 1.3× 32 0.4× 18 372
Masaaki Tomoi Japan 16 39 0.2× 283 2.4× 21 0.2× 162 1.9× 101 1.3× 39 764
Tohru Miyazawa Japan 8 240 1.4× 96 0.8× 10 0.1× 76 0.9× 46 0.6× 13 533
H Ozaki Japan 4 45 0.3× 340 2.9× 58 0.6× 252 3.0× 9 0.1× 7 702
R. S. Alphin United States 17 63 0.4× 148 1.2× 13 0.1× 86 1.0× 87 1.1× 32 591

Countries citing papers authored by Nathaniel Wallace

Since Specialization
Citations

This map shows the geographic impact of Nathaniel Wallace's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nathaniel Wallace with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nathaniel Wallace more than expected).

Fields of papers citing papers by Nathaniel Wallace

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nathaniel Wallace. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nathaniel Wallace. The network helps show where Nathaniel Wallace may publish in the future.

Co-authorship network of co-authors of Nathaniel Wallace

This figure shows the co-authorship network connecting the top 25 collaborators of Nathaniel Wallace. A scholar is included among the top collaborators of Nathaniel Wallace based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nathaniel Wallace. Nathaniel Wallace is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Kuo, Gee‐Hong, Micheal D. Gaul, Yin Liang, et al.. (2018). Synthesis and biological evaluation of benzocyclobutane-C-glycosides as potent and orally active SGLT1/SGLT2 dual inhibitors. Bioorganic & Medicinal Chemistry Letters. 28(7). 1182–1187. 29 indexed citations
2.
Hinke, Simon A., Cassandre Cavanaugh, Thomas Kirchner, et al.. (2018). Growth Differentiation Factor-15 (GDF-15) Inhibits Gastric Emptying in Rodents as Part of Its Anorectic Mechanism of Action. Diabetes. 67(Supplement_1). 2 indexed citations
3.
Xu, Guozhang, Michael D. Gaul, Gee‐Hong Kuo, et al.. (2018). Design, synthesis and biological evaluation of (2S,3R,4R,5S,6R)-5-fluoro-6-(hydroxymethyl)-2-aryltetrahydro-2H-pyran-3,4-diols as potent and orally active SGLT dual inhibitors. Bioorganic & Medicinal Chemistry Letters. 28(21). 3446–3453. 11 indexed citations
4.
Shook, Brian C., J. Kent Barbay, Aihua Wang, et al.. (2013). Substituted thieno[2,3-d]pyrimidines as adenosine A2A receptor antagonists. Bioorganic & Medicinal Chemistry Letters. 23(9). 2688–2691. 18 indexed citations
5.
Shook, Brian C., J. Kent Barbay, Aihua Wang, et al.. (2011). Aminomethyl substituted thieno[2,3-d]pyrimidines as adenosine A2A receptor antagonists. MedChemComm. 2(10). 950–950. 9 indexed citations
6.
Kimball, Edward S., Nathaniel Wallace, Craig R. Schneider, Michael R. D’Andrea, & Pamela J. Hornby. (2010). Small Intestinal Cannabinoid Receptor Changes Following a Single Colonic Insult with Oil of Mustard in Mice. Frontiers in Pharmacology. 1. 132–132. 18 indexed citations
7.
Kimball, Edward S., et al.. (2007). Stimulation of neuronal receptors, neuropeptides and cytokines during experimental oil of mustard colitis. Neurogastroenterology & Motility. 19(5). 390–400. 49 indexed citations
8.
Kimball, Edward S., Craig R. Schneider, Nathaniel Wallace, & Pamela J. Hornby. (2006). Agonists of cannabinoid receptor 1 and 2 inhibit experimental colitis induced by oil of mustard and by dextran sulfate sodium. American Journal of Physiology-Gastrointestinal and Liver Physiology. 291(2). G364–G371. 154 indexed citations
9.
Gong, Yong, J. Kent Barbay, Alexey B. Dyatkin, et al.. (2006). Synthesis and Biological Evaluation of Novel Pyridazinone-Based α4Integrin Receptor Antagonists. Journal of Medicinal Chemistry. 49(11). 3402–3411. 34 indexed citations
10.
Dyatkin, Alexey B., Yong Gong, Edward S. Kimball, et al.. (2005). Aza-bicyclic amino acid carboxamides as α4β1/α4β7 integrin receptor antagonists. Bioorganic & Medicinal Chemistry. 13(24). 6693–6702. 10 indexed citations
11.
Kimball, Edward S., Nathaniel Wallace, Craig R. Schneider, M. R. D’Andrea, & Pamela J. Hornby. (2004). Vanilloid receptor 1 antagonists attenuate disease severity in dextran sulphate sodium‐induced colitis in mice. Neurogastroenterology & Motility. 16(6). 811–818. 105 indexed citations
12.
Breslin, Henry J., Santosh V. Coutinho, Jeffrey M. Palmer, et al.. (2004). Rationale, Design, and Synthesis of Novel Phenyl Imidazoles as Opioid Receptor Agonists for Gastrointestinal Disorders. Journal of Medicinal Chemistry. 47(21). 5009–5020. 18 indexed citations
13.
Tuman, Robert W., David M. Morris, Nathaniel Wallace, & Charles R. Bowden. (1991). Inhibition of Peripheral Aromatization in the Male Cynomolgus Monkey by a Novel Nonsteroidal Aromatase Inhibitor (R 76713)*. The Journal of Clinical Endocrinology & Metabolism. 72(4). 755–760. 14 indexed citations
14.
Tuman, Robert W., Gene F. Tutwiler, John Joseph, & Nathaniel Wallace. (1988). Hypoglycaemic and hypoketonaemic effects of single and repeated oral doses of methyl palmoxirate (methyl 2‐tetradecylglycidate) in streptozotocin/alloxan‐induced diabetic dogs. British Journal of Pharmacology. 94(1). 130–136. 8 indexed citations
15.
Tutwiler, Gene F., John Joseph, & Nathaniel Wallace. (1985). Effect of methyl palmoxirate, an oral hypoglycemic agent, on epinephrine-induced hyperglycemia in the rat. Biochemical Pharmacology. 34(12). 2217–2220. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026